Takeda is a Japan-based biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical products globally, with a focus on gastroenterology, inflammation, neuroscience, plasma-derived therapies, oncology and rare diseases. The company generates revenue by selling medicines and related products to healthcare providers, hospitals, pharmacies and patients across major markets including the United States, Europe, Japan and emerging economies, supported by a geographically distributed workforce and significant investment in research and development. Takeda grows through both organic innovation and strategic business development activities including acquisitions, licensing partnerships and portfolio rationalization to enhance its product offerings and strengthen its commercial position.